(3Z)-3-[(Dimethylamino)methylidene]-1-(pyrimidin-2-yl)pyrrolidin-2-one

Catalog No. :
ACBTMC146
CAS No. :
338422-81-4
Molecular Formula :
C11H14N4O
Molecular Weight :
218.26

IUPAC Name:(Z)-3-((dimethylamino)methylene)-1-(pyrimidin-2-yl)pyrrolidin-2-one

(3Z)-3-[(Dimethylamino)methylidene]-1-(pyrimidin-2-yl)pyrrolidin-2-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$323.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(3Z)-3-[(Dimethylamino)methylidene]-1-(pyrimidin-2-yl)pyrrolidin-2-one
IUPAC Name(Z)-3-((dimethylamino)methylene)-1-(pyrimidin-2-yl)pyrrolidin-2-one
MDL No.MFCD00664563
Molecular FormulaC11H14N4O
Molecular Weight218.26
SMILESO=C1N(C2=NC=CC=N2)CC/C1=C/N(C)C
InChI KeyQXJVHCSEPMRJNP-HJWRWDBZSA-N
Synonym3-[(DIMETHYLAMINO)METHYLENE]-1-(2-PYRIMIDINYL)-2-PYRROLIDINONE;(3Z)-3-[(dimethylamino)methylidene]-1-(pyrimidin-2-yl)pyrrolidin-2-one;2-Pyrrolidinone, 3-[(dimethylamino)methylene]-1-(2-pyrimidinyl)-
CAS No.338422-81-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACBTMC146 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBTMC146 route product structure diagram
    ACBTMC146338422-81-4
Inquiry

2. ACBTMC146 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACNKTZ369 route compound structure diagram
    ACNKTZ3691722-12-9 In Stock
  4. Then
  5. ACBTMC146 route product structure diagram
    ACBTMC146338422-81-4
Inquiry

Comments (0)